“This appointment reflects positively on Natalie’s outstanding reputation in the scientific community,” said Mark Gillespie, Ph.D., SAMSF-Locke professor and chair of pharmacology at the USA College of Medicine. “As a standing member of the study section, she will be part of the group that reviews nearly all grants focusing on pathophysiologic and translational aspects of disorders directly or indirectly impacting the pulmonary circulation. In her role, Natalie will have a nationwide influence on the course of this important area of research.”
Bauer said this recognition speaks to the caliber of faculty at the USA College of Medicine. “The work we are doing here is held in high regard on both a national and international level,” she said. “It reflects that what we are doing is impactful and recognizes the value of our contributions to a greater field of science.”
Members of the study section are selected on the basis of their demonstrated competence and achievement in their scientific discipline as evidenced by the quality of research accomplishments, publications in scientific journals, and other significant scientific activities, achievements and honors.
Bauer’s primary research interests are extracellular vesicles, also known as exosomes, and pulmonary arterial hypertension.
